Northern Trust
KALA icon

Northern Trust’s KALA BIO KALA Stock Holding History

Northern Trust’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72K Buy
41,606
+41,376
+17,990% +$201K ﹤0.01% 4200
2026
Q1 		$2K Hold
230
– – ﹤0.01% 4396
2025
Q4 		$6.41K Hold
230
– – ﹤0.01% 4444
2025
Q3 		$17.6K Buy
230
+22
+11% +$10.9K ﹤0.01% 4383
2025
Q2 		$49.5K Hold
208
– – ﹤0.01% 4235
2025
Q1 		$59.6K Buy
+208
New +$78.7K ﹤0.01% 4207
2022
Q4 		– Sell
-33
Closed -$18K – 4684
2022
Q3 		$18K Hold
33
– – ﹤0.01% 4563
2022
Q2 		$25K Sell
33
-128
-80% -$201K ﹤0.01% 4587
2022
Q1 		$556K Sell
161
-19
-11% -$49.8K ﹤0.01% 3699
2021
Q4 		$543K Sell
180
-24
-12% -$111K ﹤0.01% 3778
2021
Q3 		$1.33M Buy
204
+8
+4% +$69K ﹤0.01% 3448
2021
Q2 		$2.6M Buy
196
+16
+9% +$252K ﹤0.01% 3234
2021
Q1 		$3.03M Sell
180
-13
-7% -$254K ﹤0.01% 3032
2020
Q4 		$3.26M Sell
193
-3
-2% -$56.4K ﹤0.01% 2926
2020
Q3 		$3.67M Sell
196
-20
-9% -$460K ﹤0.01% 2727
2020
Q2 		$5.66M Buy
216
+102
+89% +$2.89M ﹤0.01% 2440
2020
Q1 		$2.49M Buy
114
+20
+21% +$320K ﹤0.01% 2728
2019
Q4 		$868K Sell
94
-3
-3% -$29K ﹤0.01% 3439
2019
Q3 		$924K Buy
97
+18
+23% +$219K ﹤0.01% 3414
2019
Q2 		$1.26M Buy
79
+3
+4% +$49.7K ﹤0.01% 3279
2019
Q1 		$1.56M Hold
76
– – ﹤0.01% 3209
2018
Q4 		$925K Buy
76
+24
+46% +$416K ﹤0.01% 3387
2018
Q3 		$1.29M Buy
52
+6
+13% +$183K ﹤0.01% 3394
2018
Q2 		$1.58M Sell
46
-7
-13% -$269K ﹤0.01% 3318
2018
Q1 		$2.11M Buy
53
+24
+83% +$911K ﹤0.01% 3075
2017
Q4 		$1.35M Sell
29
-4
-12% -$187K ﹤0.01% 3311
2017
Q3 		$1.87M Buy
+33
New +$1.81M ﹤0.01% 3223

Other funds holding KALA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust's KALA Position: Q2 2026 in Review

Northern Trust increased its KALA BIO (KALA) stake by 17,990% in Q2 2026, buying an estimated $201K and bringing the position to 41,606 shares worth $72K. The position accounts for ﹤0.01% of the portfolio, ranked #4200.

Northern Trust first reported a position in KALA in Q3 2017 and has held it in 27 quarters since. The position peaked at $5.66M in Q2 2020. 14 funds tracked by Wall St. Rank hold KALA as of Q2 2026.

  • Northern Trust held 41,606 shares of KALA BIO worth $72K as of Q2 2026.
  • Northern Trust bought 41,376 KALA BIO shares in Q2 2026, an estimated $201K.
  • KALA BIO made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4200 holding.
  • Northern Trust first reported a position in KALA BIO in Q3 2017 and has held it in 27 quarters since.
  • Northern Trust's KALA BIO position peaked at $5.66M in Q2 2020.
  • 14 funds tracked by Wall St. Rank held KALA BIO as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.